Multiple sclerosis and related disorders · 2026
Evaluating the feasibility of a remote sampling method for neurofilament light chain measurements in Multiple Sclerosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gklinos Panagiotis, Vickaryous Nicola, Huxford Brook, Rios Francesca, Schalk Luisa, Holden David, Gnanapavan Sharmilee, Dobson Ruth
Аннотация
BACKGROUND/OBJECTIVES: Neurofilament light (NfL) is a biomarker of axonal damage, typically measured in CSF or venous blood. There is growing interest in the utility of remote sampling methods however limited studies of feasibility exist.
METHODS: 45 people with MS undergoing lumbar puncture were recruited and had at least one sample included. NfL levels from different biofluids and sampling methods were examined at baseline: CSF (n = 43), venous plasma (n = 29) and finger-prick dried plasma spots (fDPS, n = 39). Participants were then asked to self-collect fDPS at two, four and six months after enrolment.
RESULTS: Levels of NfL were highest in CSF with a geometric mean of 449.78 pg/ml (95% CI 334.25-605.26) compared to plasma, 71.48 pg/ml (95% CI 57.04-89.57) or fDPS 4.02pg/ml (95% CI 3.03-5.36). There was a strong correlation between CSF and venous plasma NfL, (r = 0.78, r2=0.61, p < 0.001); and venous plasma and fDPS NfL, (r = 0.71, r2=0.50, p < 0.005); and a moderate correlation between CSF and fDPS, (r = 0.44, r2=0.20, p < 0.05).
CONCLUSION: Remote self-collection of fDPS was feasible in our study with NfL levels strongly correlating with plasma while capturing CSF trends. Additionally, NfL remained stable over six months in a clinically stable population, supporting the reliability of the assay.
METHODS: 45 people with MS undergoing lumbar puncture were recruited and had at least one sample included. NfL levels from different biofluids and sampling methods were examined at baseline: CSF (n = 43), venous plasma (n = 29) and finger-prick dried plasma spots (fDPS, n = 39). Participants were then asked to self-collect fDPS at two, four and six months after enrolment.
RESULTS: Levels of NfL were highest in CSF with a geometric mean of 449.78 pg/ml (95% CI 334.25-605.26) compared to plasma, 71.48 pg/ml (95% CI 57.04-89.57) or fDPS 4.02pg/ml (95% CI 3.03-5.36). There was a strong correlation between CSF and venous plasma NfL, (r = 0.78, r2=0.61, p < 0.001); and venous plasma and fDPS NfL, (r = 0.71, r2=0.50, p < 0.005); and a moderate correlation between CSF and fDPS, (r = 0.44, r2=0.20, p < 0.05).
CONCLUSION: Remote self-collection of fDPS was feasible in our study with NfL levels strongly correlating with plasma while capturing CSF trends. Additionally, NfL remained stable over six months in a clinically stable population, supporting the reliability of the assay.